Back on December 19, 2011, CMS solicited public comment on the Physician Payment Sunshine Act, and in response, it received 373 comments. Since then pharmaceutical and medical device manufacturers have been waiting for the final rule, and late Friday, CMS finally issued it. We’ve combed through the 287-page tome and come up with a list […]
We’re about one month away from CMS providing its final guidance on the Physician Payment Sunshine Act (hopefully). And it’s about time! It’s been more than a year since CMS announced it would collect feedback on the rule before issuing final guidance. But even though we’re still waiting for the final ruling, now is the […]
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
One component of the Affordable Care Act that is of particular interest to medical device and pharmaceutical companies is the Physician Payment Sunshine Act (the Sunshine Act). For those who need a refresher, the act requires all manufacturers of drugs and medical devices to annually report any payments or other “transfers of value” to physicians […]